TECNZ logo

Tecan Group AGBATS-CHIXE:TECNZ Stock Report

Market Cap CHF 2.4b
Share Price
n/a
1Y27.7%
7D0%
1D-0.4%
Portfolio Value
​
View

Tecan Group AG

BATS-CHIXE:TECNZ Stock Report

Market Cap: CHF 2.4b

Tecan Group (TECNZ) Stock Overview

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. More details

TECNZ fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance0/6
Financial Health5/6
Dividends3/6

Rewards

Trading at 40.7% below our estimate of its fair value

Earnings are forecast to grow 49.83% per year

Trading at good value compared to peers and industry

Risk Analysis

No risks detected for TECNZ from our risk checks.

TECNZ Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW436,653 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
436,653 investors already sharing narratives
View all narratives

Tecan Group AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for Tecan Group
Historical stock prices
Current Share PriceCHF 196.60
52 Week HighCHF 201.20
52 Week LowCHF 110.60
Beta1.09
1 Month Change-1.06%
3 Month Change29.26%
1 Year Change27.66%
3 Year Change-38.49%
5 Year Change-66.65%
Change since IPO184.72%

Recent News & Updates

Recent updates

Shareholder Returns

TECNZGB Life SciencesGB Market
7D0%-5.9%-0.7%
1Y27.7%-11.0%16.1%

Return vs Industry: TECNZ exceeded the UK Life Sciences industry which returned -9.4% over the past year.

Return vs Market: TECNZ exceeded the UK Market which returned 17.3% over the past year.

Price Volatility

Is TECNZ's price volatile compared to industry and market?
TECNZ volatility
TECNZ Average Weekly Movement5.4%
Life Sciences Industry Average Movement7.0%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.3%
10% least volatile stocks in GB Market2.6%

Stable Share Price: TECNZ has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: TECNZ's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19803,000Monica Manotaswww.tecan.com

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution.

Tecan Group AG Fundamentals Summary

How do Tecan Group's earnings and revenue compare to its market cap?
TECNZ fundamental statistics
Market capCHF 2.43b
Earnings (TTM)-CHF 116.30m
Revenue (TTM)CHF 870.53m
2.8x
P/S Ratio
-20.9x
P/E Ratio

Is TECNZ overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TECNZ income statement (TTM)
RevenueCHF 870.53m
Cost of RevenueCHF 574.03m
Gross ProfitCHF 296.50m
Other ExpensesCHF 412.81m
Earnings-CHF 116.30m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

Nov 05, 2026

Earnings per share (EPS)-9.44
Gross Margin34.06%
Net Profit Margin-13.36%
Debt/Equity Ratio13.6%

How did TECNZ perform over the long term?

See historical performance and comparison

Dividends

1.5%
Current Dividend Yield
-32%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/09 20:15
End of Day Share Price 2026/09/09 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tecan Group AG is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Harry GillisBerenberg
Delphine Le LouetBernstein
Susannah LudwigBernstein